Femoral Stress Fractures Associated With Long-term Bisphosphonate Treatment
暂无分享,去创建一个
W. Ward | William G Ward | Christina J Carter | Scott C Wilson | Cynthia L Emory | Scott C. Wilson | Cynthia L. Emory | C. J. Carter
[1] N. Tejwani,et al. Bilateral low-energy simultaneous or sequential femoral fractures in patients on long-term alendronate therapy. , 2009, The Journal of bone and joint surgery. American volume.
[2] M. Goddard,et al. Atraumatic bilateral femur fracture in long-term bisphosphonate use. , 2009, Orthopedics.
[3] Thomas D Brown,et al. Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] M. Vrahas,et al. Nonoperative versus Prophylactic Treatment of Bisphosphonate-associated Femoral Stress Fractures , 2011, Clinical orthopaedics and related research.
[5] S. Cummings,et al. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial. , 2006, JAMA.
[6] American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. , 2007, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[7] A. LaCroix,et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. , 1998, JAMA.
[8] E. Barrett-Connor,et al. Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long‐Term Extension , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[9] Klaus Klaushofer,et al. Atypical subtrochanteric and diaphyseal femoral fractures: Report of a task force of the american society for bone and mineral Research , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] S. Ott. Long-term safety of bisphosphonates. , 2005, The Journal of clinical endocrinology and metabolism.
[11] T. Howe,et al. An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? , 2008, Injury.
[12] L. Assael,et al. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws--2009 update. , 2009, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[13] J. Nieves,et al. Atypical Subtrochanteric and Femoral Shaft Fractures and Possible Association with Bisphosphonates , 2010, Current osteoporosis reports.
[14] T. Howe,et al. Femoral Cortical Stress Lesions in Long-Term Bisphosphonate Therapy: A Herald of Impending Fracture? , 2010, Journal of orthopaedic trauma.
[15] W. Ward,et al. Metastatic Disease of the Femur: Surgical Treatment , 2003, Clinical orthopaedics and related research.
[16] J. Zerwekh,et al. Severely suppressed bone turnover: a potential complication of alendronate therapy. , 2005, The Journal of clinical endocrinology and metabolism.
[17] J. Schneider. Bisphosphonates and low-impact femoral fractures: current evidence on alendronate-fracture risk. , 2009, Geriatrics.
[18] D. Felsenberg,et al. Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study , 1999, Osteoporosis International.
[19] A. Sayed-Noor,et al. Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy , 2009, Clinical orthopaedics and related research.
[20] D. Lorich,et al. Low-Energy Femoral Shaft Fractures Associated With Alendronate Use , 2008, Journal of orthopaedic trauma.
[21] M. Gebhart,et al. Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy , 2010, Clinical orthopaedics and related research.